Generic Pharma Giants Beat Earnings, Stock Prices Stable
Update: 2025-11-20
Description
Generic pharmaceutical companies, a sector crucial for affordable drugs, reported robust third-quarter earnings, with revenues surpassing analyst predictions by over four percent. Amneal Pharmaceuticals led the pack with a twelve percent year-over-year revenue increase, while ANI Pharmaceuticals saw the fastest growth at over fifty-three percent. Despite these strong earnings, stock prices remained relatively stable, with Amneal and Amphastar seeing modest gains, Viatris experiencing a slight dip, and ANI Pharmaceuticals facing a significant drop.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
